Cardinal Health, Inc. (NYSE:CAH – Get Free Report) has received a consensus recommendation of “Hold” from the thirteen research firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $109.67.
Several equities research analysts have recently issued reports on the company. StockNews.com upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Monday, July 22nd. Robert W. Baird lifted their price target on Cardinal Health from $129.00 to $130.00 and gave the company an “outperform” rating in a report on Tuesday, July 9th. Wells Fargo & Company reduced their price target on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a report on Monday, April 29th. Citigroup reduced their price target on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a report on Friday, July 19th. Finally, Evercore ISI cut their price objective on Cardinal Health from $115.00 to $105.00 and set an “in-line” rating on the stock in a research note on Tuesday, July 9th.
Get Our Latest Stock Report on Cardinal Health
Institutional Trading of Cardinal Health
Cardinal Health Trading Down 1.7 %
Shares of NYSE CAH opened at $101.60 on Wednesday. Cardinal Health has a one year low of $85.11 and a one year high of $116.04. The firm has a market capitalization of $24.75 billion, a PE ratio of 45.16, a PEG ratio of 1.14 and a beta of 0.61. The business has a 50-day moving average price of $98.44 and a two-hundred day moving average price of $103.42.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $1.95 by $0.13. The firm had revenue of $54.90 billion during the quarter, compared to analyst estimates of $56.05 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company posted $1.74 EPS. Research analysts anticipate that Cardinal Health will post 7.35 EPS for the current year.
Cardinal Health Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, July 15th. Stockholders of record on Monday, July 1st were given a dividend of $0.5056 per share. The ex-dividend date was Monday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.50. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.99%. Cardinal Health’s payout ratio is currently 89.78%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- Election Stocks: How Elections Affect the Stock Market
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- What Are Dividend Contenders? Investing in Dividend Contenders
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Why Invest in 5G? How to Invest in 5G Stocks
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.